Back to Agenda
Session 3: Early Dialogue Between Regulators and HTA (and Payers & Patients)
Speaker(s)
HTA Bodies Cooperation on Early Dialogues: Recent Advances: François Meyer, MD
Advisor to the President, International Affairs
French National Authority for Health (HAS), France
Enhancing the Dialogue Beyond RCTs: Byron Jones
Executive Director
Statistical Methodology and Consulting Group, Novartis Pharma AG, Switzerland
The Imperfect Study Design – How to Deal with It?: Stefan Lange, MD
Deputy Director
Institute for Quality and Efficiency in Health Care (IQWiG), Germany
Have an account?